

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 6.92152182 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.92152182 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.74056699 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.74056699 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.26665166 |
| 6 | tryptophan catabolic process (GO:0006569) | 5.64310015 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 5.64310015 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 5.64310015 |
| 9 | cysteine metabolic process (GO:0006534) | 5.63093499 |
| 10 | glyoxylate metabolic process (GO:0046487) | 5.61637486 |
| 11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.47213084 |
| 12 | kynurenine metabolic process (GO:0070189) | 5.40181242 |
| 13 | tryptophan metabolic process (GO:0006568) | 5.33198969 |
| 14 | sulfur amino acid catabolic process (GO:0000098) | 5.14893706 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.12612663 |
| 16 | alpha-linolenic acid metabolic process (GO:0036109) | 5.11983435 |
| 17 | lysine metabolic process (GO:0006553) | 5.06329484 |
| 18 | lysine catabolic process (GO:0006554) | 5.06329484 |
| 19 | urea cycle (GO:0000050) | 5.02831450 |
| 20 | urea metabolic process (GO:0019627) | 5.02831450 |
| 21 | serine family amino acid catabolic process (GO:0009071) | 4.96796857 |
| 22 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.90775571 |
| 23 | homocysteine metabolic process (GO:0050667) | 4.73572071 |
| 24 | high-density lipoprotein particle remodeling (GO:0034375) | 4.68836278 |
| 25 | nitrogen cycle metabolic process (GO:0071941) | 4.64952308 |
| 26 | NADH metabolic process (GO:0006734) | 4.62340492 |
| 27 | aromatic amino acid family metabolic process (GO:0009072) | 4.58966484 |
| 28 | * amino-acid betaine metabolic process (GO:0006577) | 4.58689810 |
| 29 | serine family amino acid biosynthetic process (GO:0009070) | 4.57088532 |
| 30 | glycine metabolic process (GO:0006544) | 4.57081883 |
| 31 | serine family amino acid metabolic process (GO:0009069) | 4.53464711 |
| 32 | bile acid metabolic process (GO:0008206) | 4.44161568 |
| 33 | protein carboxylation (GO:0018214) | 4.43596232 |
| 34 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.43596232 |
| 35 | tricarboxylic acid cycle (GO:0006099) | 4.40455110 |
| 36 | drug catabolic process (GO:0042737) | 4.39416017 |
| 37 | biotin metabolic process (GO:0006768) | 4.38964175 |
| 38 | urate metabolic process (GO:0046415) | 4.38428107 |
| 39 | alpha-amino acid catabolic process (GO:1901606) | 4.36610662 |
| 40 | negative regulation of fibrinolysis (GO:0051918) | 4.33156922 |
| 41 | regulation of triglyceride catabolic process (GO:0010896) | 4.30847466 |
| 42 | regulation of cholesterol esterification (GO:0010872) | 4.29067615 |
| 43 | complement activation, alternative pathway (GO:0006957) | 4.25614574 |
| 44 | drug transmembrane transport (GO:0006855) | 4.24179162 |
| 45 | regulation of protein activation cascade (GO:2000257) | 4.19533852 |
| 46 | tyrosine metabolic process (GO:0006570) | 4.17022268 |
| 47 | plasma lipoprotein particle remodeling (GO:0034369) | 4.15732396 |
| 48 | protein-lipid complex remodeling (GO:0034368) | 4.15732396 |
| 49 | macromolecular complex remodeling (GO:0034367) | 4.15732396 |
| 50 | reverse cholesterol transport (GO:0043691) | 4.10244886 |
| 51 | cellular amino acid catabolic process (GO:0009063) | 4.08495562 |
| 52 | branched-chain amino acid catabolic process (GO:0009083) | 4.08296838 |
| 53 | negative regulation of cholesterol transport (GO:0032375) | 4.06105116 |
| 54 | negative regulation of sterol transport (GO:0032372) | 4.06105116 |
| 55 | regulation of fibrinolysis (GO:0051917) | 4.06007169 |
| 56 | cellular ketone body metabolic process (GO:0046950) | 4.02575068 |
| 57 | acylglycerol homeostasis (GO:0055090) | 3.98837404 |
| 58 | triglyceride homeostasis (GO:0070328) | 3.98837404 |
| 59 | cellular modified amino acid catabolic process (GO:0042219) | 3.98578317 |
| 60 | indolalkylamine metabolic process (GO:0006586) | 3.97277614 |
| 61 | L-serine metabolic process (GO:0006563) | 3.96277007 |
| 62 | phospholipid efflux (GO:0033700) | 3.93736288 |
| 63 | aldehyde catabolic process (GO:0046185) | 3.93546985 |
| 64 | bile acid and bile salt transport (GO:0015721) | 3.92431421 |
| 65 | regulation of complement activation (GO:0030449) | 3.92338722 |
| 66 | cellular biogenic amine catabolic process (GO:0042402) | 3.92176140 |
| 67 | amine catabolic process (GO:0009310) | 3.92176140 |
| 68 | ethanol oxidation (GO:0006069) | 3.91235618 |
| 69 | glutamate metabolic process (GO:0006536) | 3.90341099 |
| 70 | coenzyme catabolic process (GO:0009109) | 3.84837330 |
| 71 | benzene-containing compound metabolic process (GO:0042537) | 3.80494888 |
| 72 | epoxygenase P450 pathway (GO:0019373) | 3.77969459 |
| 73 | imidazole-containing compound metabolic process (GO:0052803) | 3.77709740 |
| 74 | short-chain fatty acid metabolic process (GO:0046459) | 3.77066553 |
| 75 | plasma lipoprotein particle clearance (GO:0034381) | 3.75871214 |
| 76 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.70977885 |
| 77 | exogenous drug catabolic process (GO:0042738) | 3.70698261 |
| 78 | drug transport (GO:0015893) | 3.70230107 |
| 79 | response to nitrosative stress (GO:0051409) | 3.69644777 |
| 80 | carboxylic acid catabolic process (GO:0046395) | 3.66101499 |
| 81 | organic acid catabolic process (GO:0016054) | 3.66101499 |
| 82 | acetyl-CoA metabolic process (GO:0006084) | 3.64440499 |
| 83 | aspartate family amino acid catabolic process (GO:0009068) | 3.64254274 |
| 84 | glucuronate metabolic process (GO:0019585) | 3.62982128 |
| 85 | uronic acid metabolic process (GO:0006063) | 3.62982128 |
| 86 | plasma lipoprotein particle assembly (GO:0034377) | 3.62981433 |
| 87 | xenobiotic catabolic process (GO:0042178) | 3.62692795 |
| 88 | cholesterol efflux (GO:0033344) | 3.60208276 |
| 89 | cellular glucuronidation (GO:0052695) | 3.59790780 |
| 90 | valine metabolic process (GO:0006573) | 3.59537102 |
| 91 | fatty acid beta-oxidation (GO:0006635) | 3.59370947 |
| 92 | primary alcohol catabolic process (GO:0034310) | 3.58544826 |
| 93 | low-density lipoprotein particle remodeling (GO:0034374) | 3.55915498 |
| 94 | COPI coating of Golgi vesicle (GO:0048205) | 3.55287979 |
| 95 | Golgi transport vesicle coating (GO:0048200) | 3.55287979 |
| 96 | phenylpropanoid metabolic process (GO:0009698) | 3.55250680 |
| 97 | fatty acid oxidation (GO:0019395) | 3.53658638 |
| 98 | branched-chain amino acid metabolic process (GO:0009081) | 3.53452053 |
| 99 | cholesterol homeostasis (GO:0042632) | 3.49946133 |
| 100 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.49727860 |
| 101 | intestinal cholesterol absorption (GO:0030299) | 3.49254673 |
| 102 | drug metabolic process (GO:0017144) | 3.48192879 |
| 103 | regulation of cholesterol homeostasis (GO:2000188) | 3.47246384 |
| 104 | ketone body metabolic process (GO:1902224) | 3.47195554 |
| 105 | lipid oxidation (GO:0034440) | 3.46889464 |
| 106 | sterol homeostasis (GO:0055092) | 3.46656292 |
| 107 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.46642745 |
| 108 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.46642745 |
| 109 | arginine metabolic process (GO:0006525) | 3.46617858 |
| 110 | ethanol metabolic process (GO:0006067) | 3.45959252 |
| 111 | polyketide metabolic process (GO:0030638) | 3.45830566 |
| 112 | doxorubicin metabolic process (GO:0044598) | 3.45830566 |
| 113 | daunorubicin metabolic process (GO:0044597) | 3.45830566 |
| 114 | 2-oxoglutarate metabolic process (GO:0006103) | 3.42738466 |
| 115 | monocarboxylic acid catabolic process (GO:0072329) | 3.42521477 |
| 116 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.41641881 |
| 117 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.41625771 |
| 118 | cofactor catabolic process (GO:0051187) | 3.41505748 |
| 119 | omega-hydroxylase P450 pathway (GO:0097267) | 3.41461873 |
| 120 | fatty acid catabolic process (GO:0009062) | 3.40036632 |
| 121 | * carnitine metabolic process (GO:0009437) | 3.39278577 |
| 122 | heme transport (GO:0015886) | 3.39043624 |
| 123 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.35799849 |
| 124 | oxaloacetate metabolic process (GO:0006107) | 3.26905223 |
| 125 | primary alcohol metabolic process (GO:0034308) | 3.23121355 |
| 126 | triglyceride catabolic process (GO:0019433) | 3.20310835 |
| 127 | very long-chain fatty acid metabolic process (GO:0000038) | 3.18258117 |
| 128 | fatty acid elongation (GO:0030497) | 3.12486168 |
| 129 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.07718121 |
| 130 | acyl-CoA metabolic process (GO:0006637) | 3.01742983 |
| 131 | thioester metabolic process (GO:0035383) | 3.01742983 |
| 132 | vitamin biosynthetic process (GO:0009110) | 2.99299253 |
| 133 | peroxisome fission (GO:0016559) | 2.98687228 |
| 134 | lipid particle organization (GO:0034389) | 2.97033392 |
| 135 | COPII vesicle coating (GO:0048208) | 2.96704224 |
| 136 | * cellular aldehyde metabolic process (GO:0006081) | 2.90730503 |
| 137 | blood coagulation, intrinsic pathway (GO:0007597) | 2.89185423 |
| 138 | neutral lipid catabolic process (GO:0046461) | 2.86933987 |
| 139 | acylglycerol catabolic process (GO:0046464) | 2.86933987 |
| 140 | gluconeogenesis (GO:0006094) | 2.85653581 |
| 141 | regulation of sequestering of triglyceride (GO:0010889) | 2.78219319 |
| 142 | fatty acid homeostasis (GO:0055089) | 2.75969719 |
| 143 | response to phenylpropanoid (GO:0080184) | 2.74230656 |
| 144 | fibrinolysis (GO:0042730) | 2.72618153 |
| 145 | tricarboxylic acid metabolic process (GO:0072350) | 2.72497622 |
| 146 | quinone metabolic process (GO:1901661) | 2.70327086 |
| 147 | hexose biosynthetic process (GO:0019319) | 2.70223755 |
| 148 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.67265066 |
| 149 | cullin deneddylation (GO:0010388) | 2.67241289 |
| 150 | succinate metabolic process (GO:0006105) | 2.65517294 |
| 151 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.62798657 |
| 152 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.58003434 |
| 153 | retinol metabolic process (GO:0042572) | 2.57784924 |
| 154 | monosaccharide biosynthetic process (GO:0046364) | 2.57265069 |
| 155 | ribosome assembly (GO:0042255) | 2.54919322 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.81237448 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.94370949 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.14837134 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.69776683 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.23597935 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.55194071 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.45885254 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.99004362 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.80463239 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.85474392 |
| 11 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.49158459 |
| 12 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.25698746 |
| 13 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.09164849 |
| 14 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 2.08937220 |
| 15 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.07440507 |
| 16 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.97625677 |
| 17 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.92739843 |
| 18 | * PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.92324364 |
| 19 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.83536214 |
| 20 | GATA1_22025678_ChIP-Seq_K562_Human | 1.80373938 |
| 21 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.77104690 |
| 22 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.69109410 |
| 23 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.67987939 |
| 24 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.57724142 |
| 25 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.52914212 |
| 26 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.50735591 |
| 27 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.46567953 |
| 28 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.45003907 |
| 29 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.44533241 |
| 30 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.43937370 |
| 31 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.43832244 |
| 32 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.41140819 |
| 33 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.39807216 |
| 34 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.36257572 |
| 35 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.32920515 |
| 36 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.31583647 |
| 37 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.29867947 |
| 38 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.29390225 |
| 39 | FUS_26573619_Chip-Seq_HEK293_Human | 1.27643697 |
| 40 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.25752777 |
| 41 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.25568327 |
| 42 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.25561014 |
| 43 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.25398084 |
| 44 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.23543812 |
| 45 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.23421109 |
| 46 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.23414364 |
| 47 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.22815414 |
| 48 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.21883508 |
| 49 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.21862007 |
| 50 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.21011100 |
| 51 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.20155020 |
| 52 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.19016934 |
| 53 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16457028 |
| 54 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.15020567 |
| 55 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.13080468 |
| 56 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.12082891 |
| 57 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.09723832 |
| 58 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.08765501 |
| 59 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.08392347 |
| 60 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.08139325 |
| 61 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.07925975 |
| 62 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.06953330 |
| 63 | CBP_21632823_ChIP-Seq_H3396_Human | 1.06940719 |
| 64 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.05841821 |
| 65 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.03662977 |
| 66 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.01386404 |
| 67 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.00694839 |
| 68 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.00296296 |
| 69 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.99668159 |
| 70 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.98901037 |
| 71 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.98831981 |
| 72 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.98445734 |
| 73 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98430689 |
| 74 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.97978909 |
| 75 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.96912801 |
| 76 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.96683613 |
| 77 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.96489650 |
| 78 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.95579765 |
| 79 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.95579765 |
| 80 | * PHF8_20622853_ChIP-Seq_HELA_Human | 0.94081114 |
| 81 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.92705709 |
| 82 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.92502125 |
| 83 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.92098313 |
| 84 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.92044569 |
| 85 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.91804513 |
| 86 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.90843986 |
| 87 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.90751960 |
| 88 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.90293206 |
| 89 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.90123686 |
| 90 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.89677752 |
| 91 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.89663717 |
| 92 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.89500457 |
| 93 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.89039024 |
| 94 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 0.88879523 |
| 95 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.88576055 |
| 96 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.88094847 |
| 97 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.87515305 |
| 98 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.87412270 |
| 99 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.87370281 |
| 100 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.87323970 |
| 101 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.87137390 |
| 102 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.87075808 |
| 103 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85417010 |
| 104 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.82566644 |
| 105 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.82084590 |
| 106 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.81909443 |
| 107 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.81196467 |
| 108 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.80113960 |
| 109 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.80082576 |
| 110 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.79755026 |
| 111 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.79068604 |
| 112 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 0.78619792 |
| 113 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.77204663 |
| 114 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.76825181 |
| 115 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.76720433 |
| 116 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.76519750 |
| 117 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.75029188 |
| 118 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.74773097 |
| 119 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.74276112 |
| 120 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.74105897 |
| 121 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.72908507 |
| 122 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.71627498 |
| 123 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.68551221 |
| 124 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.67178566 |
| 125 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.66994110 |
| 126 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.66221411 |
| 127 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.64970070 |
| 128 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.64967625 |
| 129 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.63801471 |
| 130 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.63163497 |
| 131 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.62568689 |
| 132 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.62494286 |
| 133 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.62209199 |
| 134 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.62053595 |
| 135 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.62006824 |
| 136 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.61911201 |
| 137 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.60633513 |
| 138 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.60492896 |
| 139 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.59149388 |
| 140 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58570944 |
| 141 | AR_20517297_ChIP-Seq_VCAP_Human | 0.58515856 |
| 142 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.58323328 |
| 143 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.57505236 |
| 144 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.57443177 |
| 145 | * SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.57231089 |
| 146 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.57132720 |
| 147 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.56607299 |
| 148 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.56413099 |
| 149 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.56093128 |
| 150 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.55731475 |
| 151 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.55728314 |
| 152 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.55596675 |
| 153 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.55221857 |
| 154 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.54880185 |
| 155 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.54662637 |
| 156 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.54618222 |
| 157 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.54521513 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.54555701 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 7.48694233 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.49939364 |
| 4 | MP0005365_abnormal_bile_salt | 5.42672294 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.53279545 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.34754267 |
| 7 | MP0010234_abnormal_vibrissa_follicle | 3.65397292 |
| 8 | MP0009840_abnormal_foam_cell | 3.54680721 |
| 9 | MP0003252_abnormal_bile_duct | 3.49157421 |
| 10 | MP0010329_abnormal_lipoprotein_level | 3.09733831 |
| 11 | MP0005332_abnormal_amino_acid | 2.96069233 |
| 12 | MP0003195_calcinosis | 2.69686242 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.61295591 |
| 14 | MP0005083_abnormal_biliary_tract | 2.52237541 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.40242025 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 2.36098360 |
| 17 | MP0003941_abnormal_skin_development | 2.29215614 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 2.21115921 |
| 19 | MP0000609_abnormal_liver_physiology | 2.05365682 |
| 20 | MP0004272_abnormal_basement_membrane | 1.98206365 |
| 21 | MP0003136_yellow_coat_color | 1.92613414 |
| 22 | MP0002118_abnormal_lipid_homeostasis | 1.92221370 |
| 23 | MP0002090_abnormal_vision | 1.87195585 |
| 24 | MP0003186_abnormal_redox_activity | 1.85192244 |
| 25 | MP0005319_abnormal_enzyme/_coenzyme | 1.84318060 |
| 26 | MP0009643_abnormal_urine_homeostasis | 1.77532586 |
| 27 | MP0000372_irregular_coat_pigmentation | 1.77437864 |
| 28 | MP0001764_abnormal_homeostasis | 1.73380426 |
| 29 | MP0005171_absent_coat_pigmentation | 1.65693421 |
| 30 | MP0005451_abnormal_body_composition | 1.63085784 |
| 31 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.58307481 |
| 32 | MP0003868_abnormal_feces_composition | 1.54971984 |
| 33 | MP0006054_spinal_hemorrhage | 1.54301925 |
| 34 | MP0003656_abnormal_erythrocyte_physiolo | 1.52783929 |
| 35 | MP0010352_gastrointestinal_tract_polyps | 1.52067565 |
| 36 | MP0001881_abnormal_mammary_gland | 1.43952696 |
| 37 | MP0005636_abnormal_mineral_homeostasis | 1.27188431 |
| 38 | MP0000598_abnormal_liver_morphology | 1.26313768 |
| 39 | MP0009697_abnormal_copulation | 1.25180703 |
| 40 | MP0000749_muscle_degeneration | 1.25089625 |
| 41 | MP0008438_abnormal_cutaneous_collagen | 1.21842387 |
| 42 | MP0004215_abnormal_myocardial_fiber | 1.21405155 |
| 43 | MP0000751_myopathy | 1.20969578 |
| 44 | MP0006036_abnormal_mitochondrial_physio | 1.20943202 |
| 45 | MP0002909_abnormal_adrenal_gland | 1.17878942 |
| 46 | MP0002796_impaired_skin_barrier | 1.16461934 |
| 47 | MP0005670_abnormal_white_adipose | 1.15778562 |
| 48 | MP0003011_delayed_dark_adaptation | 1.14468190 |
| 49 | MP0005275_abnormal_skin_tensile | 1.12657031 |
| 50 | MP0009780_abnormal_chondrocyte_physiolo | 1.12171007 |
| 51 | MP0003566_abnormal_cell_adhesion | 1.11206446 |
| 52 | MP0002638_abnormal_pupillary_reflex | 1.07789686 |
| 53 | MP0004043_abnormal_pH_regulation | 1.07617912 |
| 54 | MP0002295_abnormal_pulmonary_circulatio | 1.05876814 |
| 55 | MP0002938_white_spotting | 1.05607673 |
| 56 | MP0005248_abnormal_Harderian_gland | 1.05275378 |
| 57 | MP0008469_abnormal_protein_level | 1.04835146 |
| 58 | MP0003718_maternal_effect | 1.03844923 |
| 59 | MP0009763_increased_sensitivity_to | 1.02179078 |
| 60 | MP0005058_abnormal_lysosome_morphology | 1.00068091 |
| 61 | MP0002877_abnormal_melanocyte_morpholog | 1.00006227 |
| 62 | MP0005408_hypopigmentation | 0.97349780 |
| 63 | MP0009764_decreased_sensitivity_to | 0.95874474 |
| 64 | MP0005375_adipose_tissue_phenotype | 0.95828758 |
| 65 | MP0001756_abnormal_urination | 0.93988795 |
| 66 | MP0000371_diluted_coat_color | 0.93918405 |
| 67 | MP0000013_abnormal_adipose_tissue | 0.91922133 |
| 68 | MP0005220_abnormal_exocrine_pancreas | 0.91472546 |
| 69 | MP0001324_abnormal_eye_pigmentation | 0.90767462 |
| 70 | MP0002060_abnormal_skin_morphology | 0.90178121 |
| 71 | MP0005187_abnormal_penis_morphology | 0.90088751 |
| 72 | MP0009642_abnormal_blood_homeostasis | 0.89571402 |
| 73 | MP0004233_abnormal_muscle_weight | 0.88984853 |
| 74 | MP0006138_congestive_heart_failure | 0.88577562 |
| 75 | MP0003959_abnormal_lean_body | 0.87483288 |
| 76 | MP0005330_cardiomyopathy | 0.87217149 |
| 77 | MP0005647_abnormal_sex_gland | 0.87011008 |
| 78 | MP0002136_abnormal_kidney_physiology | 0.87006948 |
| 79 | MP0008058_abnormal_DNA_repair | 0.86411004 |
| 80 | MP0000604_amyloidosis | 0.86224993 |
| 81 | MP0005084_abnormal_gallbladder_morpholo | 0.85791910 |
| 82 | MP0004957_abnormal_blastocyst_morpholog | 0.84761119 |
| 83 | MP0005174_abnormal_tail_pigmentation | 0.83854518 |
| 84 | MP0009703_decreased_birth_body | 0.83380040 |
| 85 | MP0009765_abnormal_xenobiotic_induced | 0.82530017 |
| 86 | MP0000015_abnormal_ear_pigmentation | 0.82213772 |
| 87 | MP0000003_abnormal_adipose_tissue | 0.81163943 |
| 88 | MP0003567_abnormal_fetal_cardiomyocyte | 0.80958831 |
| 89 | MP0004264_abnormal_extraembryonic_tissu | 0.80779405 |
| 90 | MP0005464_abnormal_platelet_physiology | 0.79449473 |
| 91 | MP0000647_abnormal_sebaceous_gland | 0.78341715 |
| 92 | MP0005376_homeostasis/metabolism_phenot | 0.77387726 |
| 93 | MP0002078_abnormal_glucose_homeostasis | 0.76897432 |
| 94 | MP0008007_abnormal_cellular_replicative | 0.76600223 |
| 95 | MP0002269_muscular_atrophy | 0.76162962 |
| 96 | MP0005253_abnormal_eye_physiology | 0.75707212 |
| 97 | MP0001984_abnormal_olfaction | 0.74646787 |
| 98 | MP0005367_renal/urinary_system_phenotyp | 0.74590221 |
| 99 | MP0000516_abnormal_urinary_system | 0.74590221 |
| 100 | MP0009384_cardiac_valve_regurgitation | 0.74292076 |
| 101 | MP0003436_decreased_susceptibility_to | 0.73995167 |
| 102 | MP0003705_abnormal_hypodermis_morpholog | 0.73932579 |
| 103 | MP0001186_pigmentation_phenotype | 0.72678234 |
| 104 | MP0008260_abnormal_autophagy | 0.72081174 |
| 105 | MP0000569_abnormal_digit_pigmentation | 0.70824439 |
| 106 | MP0003724_increased_susceptibility_to | 0.70123988 |
| 107 | MP0005266_abnormal_metabolism | 0.69233526 |
| 108 | MP0001661_extended_life_span | 0.69060456 |
| 109 | MP0005385_cardiovascular_system_phenoty | 0.68044620 |
| 110 | MP0001544_abnormal_cardiovascular_syste | 0.68044620 |
| 111 | MP0000747_muscle_weakness | 0.67474404 |
| 112 | MP0002971_abnormal_brown_adipose | 0.65340034 |
| 113 | MP0005395_other_phenotype | 0.63798394 |
| 114 | MP0006035_abnormal_mitochondrial_morpho | 0.62286913 |
| 115 | MP0002254_reproductive_system_inflammat | 0.61962676 |
| 116 | MP0004147_increased_porphyrin_level | 0.61802411 |
| 117 | MP0005334_abnormal_fat_pad | 0.61198706 |
| 118 | MP0002876_abnormal_thyroid_physiology | 0.61039856 |
| 119 | MP0001765_abnormal_ion_homeostasis | 0.59775860 |
| 120 | MP0005666_abnormal_adipose_tissue | 0.58776841 |
| 121 | MP0003300_gastrointestinal_ulcer | 0.58626993 |
| 122 | MP0001853_heart_inflammation | 0.58254431 |
| 123 | MP0008873_increased_physiological_sensi | 0.58116010 |
| 124 | MP0001845_abnormal_inflammatory_respons | 0.57458816 |
| 125 | MP0005535_abnormal_body_temperature | 0.52230770 |
| 126 | MP0003638_abnormal_response/metabolism_ | 0.49823234 |
| 127 | MP0000639_abnormal_adrenal_gland | 0.48364567 |
| 128 | MP0004782_abnormal_surfactant_physiolog | 0.47953757 |
| 129 | MP0006082_CNS_inflammation | 0.47158997 |
| 130 | MP0010368_abnormal_lymphatic_system | 0.47008977 |
| 131 | MP0002970_abnormal_white_adipose | 0.46117749 |
| 132 | MP0009672_abnormal_birth_weight | 0.45654723 |
| 133 | MP0003690_abnormal_glial_cell | 0.43050909 |
| 134 | MP0005025_abnormal_response_to | 0.41995145 |
| 135 | MP0002928_abnormal_bile_duct | 0.41783723 |
| 136 | MP0002419_abnormal_innate_immunity | 0.41732876 |
| 137 | MP0005448_abnormal_energy_balance | 0.41000045 |
| 138 | MP0002135_abnormal_kidney_morphology | 0.40945616 |
| 139 | MP0001835_abnormal_antigen_presentation | 0.40269663 |
| 140 | MP0003953_abnormal_hormone_level | 0.39836052 |
| 141 | MP0004130_abnormal_muscle_cell | 0.38224849 |
| 142 | MP0009115_abnormal_fat_cell | 0.37389311 |
| 143 | MP0003329_amyloid_beta_deposits | 0.34467360 |
| 144 | MP0010155_abnormal_intestine_physiology | 0.33948756 |
| 145 | MP0009785_altered_susceptibility_to | 0.33062926 |
| 146 | MP0000230_abnormal_systemic_arterial | 0.32948631 |
| 147 | MP0009053_abnormal_anal_canal | 0.32724265 |
| 148 | MP0002132_abnormal_respiratory_system | 0.32519797 |
| 149 | MP0003699_abnormal_female_reproductive | 0.32479899 |
| 150 | MP0005075_abnormal_melanosome_morpholog | 0.32217778 |
| 151 | MP0000685_abnormal_immune_system | 0.31642751 |
| 152 | MP0008872_abnormal_physiological_respon | 0.31176822 |
| 153 | MP0000249_abnormal_blood_vessel | 0.31110140 |
| 154 | MP0000689_abnormal_spleen_morphology | 0.30945401 |
| 155 | MP0003172_abnormal_lysosome_physiology | 0.30181780 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.65918244 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 6.39293611 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.97254686 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.66592838 |
| 5 | Xanthomatosis (HP:0000991) | 5.44280496 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 5.42655035 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 4.93681037 |
| 8 | Hyperammonemia (HP:0001987) | 4.56622926 |
| 9 | Hyperglycinuria (HP:0003108) | 4.52999880 |
| 10 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.52944178 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 4.35006335 |
| 12 | Ketosis (HP:0001946) | 4.27218233 |
| 13 | Abnormality of glycine metabolism (HP:0010895) | 4.25164198 |
| 14 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.25164198 |
| 15 | Increased serum pyruvate (HP:0003542) | 4.18801734 |
| 16 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.18588276 |
| 17 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.17605330 |
| 18 | Hyperglycinemia (HP:0002154) | 4.14326386 |
| 19 | Hypoglycemic coma (HP:0001325) | 4.11176049 |
| 20 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.08444019 |
| 21 | Abnormality of glycolysis (HP:0004366) | 3.99689178 |
| 22 | Complement deficiency (HP:0004431) | 3.98200970 |
| 23 | Hypolipoproteinemia (HP:0010981) | 3.96251447 |
| 24 | Joint hemorrhage (HP:0005261) | 3.96205806 |
| 25 | Abnormality of methionine metabolism (HP:0010901) | 3.77890635 |
| 26 | Fat malabsorption (HP:0002630) | 3.77438433 |
| 27 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.69163039 |
| 28 | Epidermoid cyst (HP:0200040) | 3.68904622 |
| 29 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.62778673 |
| 30 | Abnormality of the common coagulation pathway (HP:0010990) | 3.61467552 |
| 31 | Abnormality of nucleobase metabolism (HP:0010932) | 3.55692430 |
| 32 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.41132404 |
| 33 | Ketoacidosis (HP:0001993) | 3.40886732 |
| 34 | Abnormality of purine metabolism (HP:0004352) | 3.29316636 |
| 35 | Hypoalphalipoproteinemia (HP:0003233) | 3.28626601 |
| 36 | Gout (HP:0001997) | 3.24584296 |
| 37 | Abnormality of the intrinsic pathway (HP:0010989) | 3.23263502 |
| 38 | Hyperbilirubinemia (HP:0002904) | 3.19871632 |
| 39 | Conjugated hyperbilirubinemia (HP:0002908) | 3.13337340 |
| 40 | Generalized aminoaciduria (HP:0002909) | 3.10856779 |
| 41 | Delayed CNS myelination (HP:0002188) | 3.05950566 |
| 42 | Abnormality of serum amino acid levels (HP:0003112) | 3.04042440 |
| 43 | Hypercholesterolemia (HP:0003124) | 3.00982344 |
| 44 | Patchy hypopigmentation of hair (HP:0011365) | 2.96709037 |
| 45 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.96338133 |
| 46 | Dicarboxylic aciduria (HP:0003215) | 2.96338133 |
| 47 | Abnormality of complement system (HP:0005339) | 2.95597724 |
| 48 | Metabolic acidosis (HP:0001942) | 2.90336097 |
| 49 | Symptomatic seizures (HP:0011145) | 2.87864099 |
| 50 | Steatorrhea (HP:0002570) | 2.84841754 |
| 51 | Abnormality of the anterior horn cell (HP:0006802) | 2.76480241 |
| 52 | Degeneration of anterior horn cells (HP:0002398) | 2.76480241 |
| 53 | Lethargy (HP:0001254) | 2.72882170 |
| 54 | Exercise-induced muscle cramps (HP:0003710) | 2.71992833 |
| 55 | Proximal tubulopathy (HP:0000114) | 2.71673988 |
| 56 | Hepatocellular carcinoma (HP:0001402) | 2.64776229 |
| 57 | Malnutrition (HP:0004395) | 2.62138259 |
| 58 | Rhabdomyolysis (HP:0003201) | 2.57342889 |
| 59 | Acute encephalopathy (HP:0006846) | 2.54757444 |
| 60 | Myoglobinuria (HP:0002913) | 2.46921419 |
| 61 | Acanthocytosis (HP:0001927) | 2.46706288 |
| 62 | Hypoglycemic seizures (HP:0002173) | 2.45284728 |
| 63 | Irritability (HP:0000737) | 2.44643249 |
| 64 | White forelock (HP:0002211) | 2.44245096 |
| 65 | Late onset (HP:0003584) | 2.44109217 |
| 66 | Spastic diplegia (HP:0001264) | 2.43932076 |
| 67 | Glycosuria (HP:0003076) | 2.43277675 |
| 68 | Abnormality of urine glucose concentration (HP:0011016) | 2.43277675 |
| 69 | Alkalosis (HP:0001948) | 2.43013565 |
| 70 | Vascular calcification (HP:0004934) | 2.42023734 |
| 71 | Myocardial infarction (HP:0001658) | 2.39975107 |
| 72 | Nausea (HP:0002018) | 2.39692642 |
| 73 | Systemic lupus erythematosus (HP:0002725) | 2.37794876 |
| 74 | Hyperuricemia (HP:0002149) | 2.35586970 |
| 75 | Increased purine levels (HP:0004368) | 2.35586970 |
| 76 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.32207591 |
| 77 | Pancreatitis (HP:0001733) | 2.31608286 |
| 78 | Hypochromic microcytic anemia (HP:0004840) | 2.30436881 |
| 79 | Reduced antithrombin III activity (HP:0001976) | 2.30343289 |
| 80 | Hydroxyprolinuria (HP:0003080) | 2.24441204 |
| 81 | Abnormality of proline metabolism (HP:0010907) | 2.24441204 |
| 82 | Vomiting (HP:0002013) | 2.24234332 |
| 83 | Skin nodule (HP:0200036) | 2.23180195 |
| 84 | Metaphyseal dysplasia (HP:0100255) | 2.22097004 |
| 85 | Abnormality of vitamin metabolism (HP:0100508) | 2.21201909 |
| 86 | Microglossia (HP:0000171) | 2.18789962 |
| 87 | Cerebral edema (HP:0002181) | 2.18719902 |
| 88 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.17882471 |
| 89 | Papillary thyroid carcinoma (HP:0002895) | 2.15849265 |
| 90 | Vertebral compression fractures (HP:0002953) | 2.13872350 |
| 91 | Brushfield spots (HP:0001088) | 2.11623517 |
| 92 | Hepatic necrosis (HP:0002605) | 2.10802276 |
| 93 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.09572323 |
| 94 | Sensorimotor neuropathy (HP:0007141) | 2.07918658 |
| 95 | Neonatal onset (HP:0003623) | 2.06071890 |
| 96 | Cardiovascular calcification (HP:0011915) | 2.04859543 |
| 97 | Abnormal gallbladder physiology (HP:0012438) | 2.04472384 |
| 98 | Cholecystitis (HP:0001082) | 2.04472384 |
| 99 | Abnormality of iron homeostasis (HP:0011031) | 2.04263842 |
| 100 | Abnormal gallbladder morphology (HP:0012437) | 2.03000359 |
| 101 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.02231376 |
| 102 | Opisthotonus (HP:0002179) | 2.01034391 |
| 103 | Glomerulonephritis (HP:0000099) | 2.01030797 |
| 104 | Rickets (HP:0002748) | 1.98994938 |
| 105 | Acute necrotizing encephalopathy (HP:0006965) | 1.98228315 |
| 106 | Neoplasm of the adrenal gland (HP:0100631) | 1.98015104 |
| 107 | Spontaneous abortion (HP:0005268) | 1.97822844 |
| 108 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.96591707 |
| 109 | Hypokinesia (HP:0002375) | 1.96496723 |
| 110 | Poikilocytosis (HP:0004447) | 1.96226915 |
| 111 | Spastic paraparesis (HP:0002313) | 1.94343307 |
| 112 | Type I transferrin isoform profile (HP:0003642) | 1.94284183 |
| 113 | Cholelithiasis (HP:0001081) | 1.94130709 |
| 114 | Gingival bleeding (HP:0000225) | 1.93921904 |
| 115 | Abnormal cartilage morphology (HP:0002763) | 1.93887682 |
| 116 | Renal cortical cysts (HP:0000803) | 1.93402079 |
| 117 | Methylmalonic acidemia (HP:0002912) | 1.92241443 |
| 118 | Elevated alkaline phosphatase (HP:0003155) | 1.91830299 |
| 119 | Oligomenorrhea (HP:0000876) | 1.91263564 |
| 120 | Nemaline bodies (HP:0003798) | 1.90211817 |
| 121 | Enlarged kidneys (HP:0000105) | 1.87509788 |
| 122 | Menorrhagia (HP:0000132) | 1.86584865 |
| 123 | Gonadotropin excess (HP:0000837) | 1.86542460 |
| 124 | Esophageal varix (HP:0002040) | 1.86174267 |
| 125 | Thrombophlebitis (HP:0004418) | 1.85073666 |
| 126 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.85034698 |
| 127 | Elevated hepatic transaminases (HP:0002910) | 1.84891508 |
| 128 | Progressive macrocephaly (HP:0004481) | 1.81604900 |
| 129 | Megaloblastic anemia (HP:0001889) | 1.81185897 |
| 130 | Multiple enchondromatosis (HP:0005701) | 1.80873794 |
| 131 | Mitral stenosis (HP:0001718) | 1.80867336 |
| 132 | Large for gestational age (HP:0001520) | 1.76825538 |
| 133 | Beaking of vertebral bodies (HP:0004568) | 1.75382204 |
| 134 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.73361194 |
| 135 | Thyroid carcinoma (HP:0002890) | 1.71407459 |
| 136 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.70108314 |
| 137 | Abnormality of alanine metabolism (HP:0010916) | 1.70108314 |
| 138 | Hyperalaninemia (HP:0003348) | 1.70108314 |
| 139 | Paraparesis (HP:0002385) | 1.69958666 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.31578668 |
| 2 | MST4 | 4.08131689 |
| 3 | TAF1 | 3.83164849 |
| 4 | ERN1 | 3.73070606 |
| 5 | TAOK3 | 3.21310627 |
| 6 | PDK2 | 3.01809637 |
| 7 | TSSK6 | 2.97584034 |
| 8 | FGFR4 | 2.79211025 |
| 9 | SIK1 | 2.56200267 |
| 10 | FLT3 | 2.56164149 |
| 11 | TESK1 | 2.37117570 |
| 12 | ERBB4 | 2.14190966 |
| 13 | EIF2AK1 | 2.10854568 |
| 14 | MAP4K2 | 2.08231938 |
| 15 | MAP3K12 | 1.98807838 |
| 16 | TRIM28 | 1.96684177 |
| 17 | WNK4 | 1.87891476 |
| 18 | PKN2 | 1.86944653 |
| 19 | TYK2 | 1.82757898 |
| 20 | MYLK | 1.79304415 |
| 21 | FER | 1.73438064 |
| 22 | PNCK | 1.72734436 |
| 23 | INSRR | 1.70553242 |
| 24 | ERBB3 | 1.70086425 |
| 25 | MAPK11 | 1.67771501 |
| 26 | LIMK1 | 1.65929418 |
| 27 | MST1R | 1.60440304 |
| 28 | GRK6 | 1.58131924 |
| 29 | MAP4K1 | 1.55237007 |
| 30 | STK16 | 1.55019155 |
| 31 | PLK3 | 1.51380281 |
| 32 | TRIB3 | 1.50199546 |
| 33 | ABL2 | 1.45396673 |
| 34 | VRK2 | 1.44467966 |
| 35 | NEK9 | 1.42241870 |
| 36 | SRPK1 | 1.39009468 |
| 37 | STK24 | 1.38291654 |
| 38 | PAK4 | 1.35863422 |
| 39 | ACVR1B | 1.35815712 |
| 40 | MKNK2 | 1.33598362 |
| 41 | PBK | 1.32356809 |
| 42 | MAP3K6 | 1.31576927 |
| 43 | NEK1 | 1.28717488 |
| 44 | WNK3 | 1.25865967 |
| 45 | IRAK3 | 1.25392656 |
| 46 | EPHA3 | 1.24515228 |
| 47 | TTK | 1.24477647 |
| 48 | KDR | 1.18347127 |
| 49 | STK10 | 1.16777205 |
| 50 | CSNK1G1 | 1.16344153 |
| 51 | NME2 | 1.15773388 |
| 52 | EEF2K | 1.14192912 |
| 53 | PTK6 | 1.10825124 |
| 54 | JAK2 | 1.10802243 |
| 55 | MAP3K10 | 1.10355416 |
| 56 | TBK1 | 1.10260545 |
| 57 | MAP2K3 | 1.07881105 |
| 58 | KIT | 1.05655885 |
| 59 | PIK3CG | 1.05080719 |
| 60 | STK38L | 1.03490384 |
| 61 | BMPR1B | 1.01103734 |
| 62 | AKT2 | 1.00497192 |
| 63 | MAP3K11 | 0.97437538 |
| 64 | MKNK1 | 0.97363847 |
| 65 | OBSCN | 0.95065896 |
| 66 | MAP3K2 | 0.94024802 |
| 67 | OXSR1 | 0.93888363 |
| 68 | CSNK1G3 | 0.93418065 |
| 69 | MAP3K14 | 0.93131054 |
| 70 | IRAK4 | 0.92524622 |
| 71 | CSNK1G2 | 0.91808390 |
| 72 | MAP3K8 | 0.91784509 |
| 73 | BTK | 0.91285385 |
| 74 | CCNB1 | 0.87964661 |
| 75 | CDK4 | 0.86942419 |
| 76 | MAPK15 | 0.86591942 |
| 77 | PRKD3 | 0.84074557 |
| 78 | NEK2 | 0.83219640 |
| 79 | BLK | 0.82748423 |
| 80 | CDK6 | 0.81916446 |
| 81 | NLK | 0.81380040 |
| 82 | EPHB1 | 0.80842983 |
| 83 | TEC | 0.80091286 |
| 84 | CSF1R | 0.79856362 |
| 85 | PLK1 | 0.78566594 |
| 86 | PRKAA2 | 0.78438830 |
| 87 | VRK1 | 0.77675072 |
| 88 | EIF2AK3 | 0.77450264 |
| 89 | TESK2 | 0.76531512 |
| 90 | PIM1 | 0.76102057 |
| 91 | MET | 0.75187244 |
| 92 | CSK | 0.74175329 |
| 93 | NTRK1 | 0.73861844 |
| 94 | ZAP70 | 0.73289554 |
| 95 | LRRK2 | 0.73138500 |
| 96 | WEE1 | 0.73059382 |
| 97 | STK39 | 0.73055856 |
| 98 | MAP2K2 | 0.72673483 |
| 99 | LATS1 | 0.72646537 |
| 100 | YES1 | 0.72340482 |
| 101 | SCYL2 | 0.69815222 |
| 102 | STK3 | 0.69546772 |
| 103 | PASK | 0.67602200 |
| 104 | JAK3 | 0.67443545 |
| 105 | STK4 | 0.65506539 |
| 106 | CASK | 0.63864584 |
| 107 | PLK2 | 0.63071649 |
| 108 | MAPK4 | 0.60906009 |
| 109 | PHKG2 | 0.60851086 |
| 110 | PHKG1 | 0.60851086 |
| 111 | CSNK1A1L | 0.59365969 |
| 112 | MAP3K3 | 0.58767578 |
| 113 | JAK1 | 0.56956899 |
| 114 | BCR | 0.56860626 |
| 115 | MAP2K4 | 0.56000074 |
| 116 | PRKCE | 0.54499977 |
| 117 | CDK7 | 0.54478906 |
| 118 | FGFR2 | 0.54321368 |
| 119 | PINK1 | 0.54024892 |
| 120 | RPS6KA4 | 0.53722572 |
| 121 | PIM2 | 0.53544528 |
| 122 | IKBKE | 0.51653213 |
| 123 | ITK | 0.50461004 |
| 124 | IGF1R | 0.50235368 |
| 125 | BUB1 | 0.49811281 |
| 126 | EIF2AK2 | 0.49477039 |
| 127 | LYN | 0.48021800 |
| 128 | CDC7 | 0.47228135 |
| 129 | MAPKAPK3 | 0.47175093 |
| 130 | CAMK2G | 0.46743461 |
| 131 | GSK3A | 0.46356203 |
| 132 | PRKAA1 | 0.46283412 |
| 133 | PDGFRA | 0.46154355 |
| 134 | DYRK1B | 0.46076861 |
| 135 | DAPK1 | 0.45373648 |
| 136 | STK38 | 0.45052076 |
| 137 | BRSK2 | 0.44060241 |
| 138 | IKBKB | 0.43693562 |
| 139 | CAMK1G | 0.43391091 |
| 140 | BRAF | 0.43356888 |
| 141 | MAP2K6 | 0.42905188 |
| 142 | PLK4 | 0.41809789 |
| 143 | ERBB2 | 0.40818918 |
| 144 | ILK | 0.38917389 |
| 145 | PRKACG | 0.38161487 |
| 146 | AURKB | 0.37995694 |
| 147 | ROCK2 | 0.37983448 |
| 148 | ALK | 0.37811410 |
| 149 | TIE1 | 0.37650183 |
| 150 | PDK3 | 0.36691461 |
| 151 | PDK4 | 0.36691461 |
| 152 | CAMK2D | 0.36351504 |
| 153 | MAP3K5 | 0.35695178 |
| 154 | FRK | 0.34714360 |
| 155 | PRKD1 | 0.34668207 |
| 156 | CHUK | 0.34272508 |
| 157 | FGFR1 | 0.31667700 |
| 158 | CSNK2A1 | 0.31529326 |
| 159 | ATM | 0.31515889 |
| 160 | PTK2 | 0.30313520 |
| 161 | EPHA2 | 0.29128081 |
| 162 | CDK3 | 0.28829983 |
| 163 | DDR2 | 0.28026074 |
| 164 | LMTK2 | 0.27317622 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.78377601 |
| 2 | * Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.25247692 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.02078325 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.77281163 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.69424953 |
| 6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.65354182 |
| 7 | * Tryptophan metabolism_Homo sapiens_hsa00380 | 2.59467231 |
| 8 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.58843000 |
| 9 | * Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.52709664 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.52298890 |
| 11 | * Fatty acid degradation_Homo sapiens_hsa00071 | 2.47774998 |
| 12 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.40678962 |
| 13 | Peroxisome_Homo sapiens_hsa04146 | 2.19670996 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.14912319 |
| 15 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.13911370 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.07146371 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.92733697 |
| 18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.84349146 |
| 19 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.81883905 |
| 20 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.79477438 |
| 21 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.78200756 |
| 22 | * Histidine metabolism_Homo sapiens_hsa00340 | 1.77883858 |
| 23 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.76790118 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.70246904 |
| 25 | Proteasome_Homo sapiens_hsa03050 | 1.69931271 |
| 26 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.69899202 |
| 27 | * beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.67566048 |
| 28 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.67467978 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.65340785 |
| 30 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.64739071 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.64270931 |
| 32 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.57961526 |
| 33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.55553554 |
| 34 | Retinol metabolism_Homo sapiens_hsa00830 | 1.51393452 |
| 35 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.50206884 |
| 36 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.48681257 |
| 37 | * Pyruvate metabolism_Homo sapiens_hsa00620 | 1.45197685 |
| 38 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.44783306 |
| 39 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.39228800 |
| 40 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.37811199 |
| 41 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.37274141 |
| 42 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.36228545 |
| 43 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.35299032 |
| 44 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.35140654 |
| 45 | Bile secretion_Homo sapiens_hsa04976 | 1.33605532 |
| 46 | Carbon metabolism_Homo sapiens_hsa01200 | 1.33480600 |
| 47 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.33205688 |
| 48 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.32873341 |
| 49 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.30168653 |
| 50 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.24155257 |
| 51 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.21095822 |
| 52 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.19331779 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.17543811 |
| 54 | * Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.10122613 |
| 55 | ABC transporters_Homo sapiens_hsa02010 | 1.09310151 |
| 56 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.02544461 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.00568798 |
| 58 | Sulfur relay system_Homo sapiens_hsa04122 | 0.99106107 |
| 59 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.98021375 |
| 60 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.94662668 |
| 61 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.88551900 |
| 62 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.84571558 |
| 63 | * Lysine degradation_Homo sapiens_hsa00310 | 0.83711935 |
| 64 | * Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.82457426 |
| 65 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.79657767 |
| 66 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.67232596 |
| 67 | * Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66349554 |
| 68 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.64234777 |
| 69 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.58899073 |
| 70 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.57770494 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.55800822 |
| 72 | Parkinsons disease_Homo sapiens_hsa05012 | 0.52372677 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.49157182 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.45895729 |
| 75 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.44263568 |
| 76 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42627857 |
| 77 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.42422589 |
| 78 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.41963628 |
| 79 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.37577598 |
| 80 | Other glycan degradation_Homo sapiens_hsa00511 | 0.32317937 |
| 81 | Huntingtons disease_Homo sapiens_hsa05016 | 0.29641851 |
| 82 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.28488696 |
| 83 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.26572446 |
| 84 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.26403238 |
| 85 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.23881469 |
| 86 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.23728683 |
| 87 | Circadian rhythm_Homo sapiens_hsa04710 | 0.23566831 |
| 88 | Purine metabolism_Homo sapiens_hsa00230 | 0.23488364 |
| 89 | Alzheimers disease_Homo sapiens_hsa05010 | 0.21322041 |
| 90 | DNA replication_Homo sapiens_hsa03030 | 0.20217141 |
| 91 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.19209157 |
| 92 | Protein export_Homo sapiens_hsa03060 | 0.18411855 |
| 93 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.18350034 |
| 94 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.17301894 |
| 95 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.16636213 |
| 96 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.15287497 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.14501070 |
| 98 | RNA degradation_Homo sapiens_hsa03018 | 0.14119504 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.12331925 |
| 100 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.07168053 |
| 101 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.06563725 |
| 102 | Lysosome_Homo sapiens_hsa04142 | 0.04153779 |
| 103 | Prion diseases_Homo sapiens_hsa05020 | 0.02309457 |
| 104 | Mismatch repair_Homo sapiens_hsa03430 | 0.01128355 |
| 105 | Hepatitis C_Homo sapiens_hsa05160 | -0.1235389 |
| 106 | Legionellosis_Homo sapiens_hsa05134 | -0.1152329 |
| 107 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1040275 |
| 108 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0905631 |
| 109 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0758113 |
| 110 | Homologous recombination_Homo sapiens_hsa03440 | -0.0618302 |
| 111 | Mineral absorption_Homo sapiens_hsa04978 | -0.0608764 |
| 112 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0583192 |
| 113 | Base excision repair_Homo sapiens_hsa03410 | -0.0373151 |
| 114 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0296816 |
| 115 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0262344 |
| 116 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | -0.0130552 |

